Steven P Dunn

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. ncbi request reprint Drug-drug interactions associated with antiplatelet therapy
    Steven P Dunn
    Department of Pharmacy Services, University of Virginia Health System, PO Box 800674, Charlottesville, Virginia 22908 0674, USA
    Cardiovasc Hematol Agents Med Chem 9:231-40. 2011
  2. pmc Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials
    Steven P Dunn
    University of Virginia Health System, Charlottesville, VA 22908 0674, USA
    J Am Heart Assoc 2:e004564. 2013
  3. doi request reprint Drug-drug interactions in cardiovascular catheterizations and interventions
    Steven P Dunn
    Department of Pharmacy Services, University of Virginia, Charlottesville, Virginia, USA
    JACC Cardiovasc Interv 5:1195-208. 2012
  4. ncbi request reprint Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction
    Michael P Dorsch
    Department of Pharmacy Services, University of Michigan Hospitals and Health Centers, Ann Arbor, MI, USA
    Ann Pharmacother 41:737-41. 2007

Detail Information

Publications4

  1. ncbi request reprint Drug-drug interactions associated with antiplatelet therapy
    Steven P Dunn
    Department of Pharmacy Services, University of Virginia Health System, PO Box 800674, Charlottesville, Virginia 22908 0674, USA
    Cardiovasc Hematol Agents Med Chem 9:231-40. 2011
    ..However, the full significance of these DDIs is largely unknown due to reliance on research of voluntary reports, registries, and claims databases to determine significance. ..
  2. pmc Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials
    Steven P Dunn
    University of Virginia Health System, Charlottesville, VA 22908 0674, USA
    J Am Heart Assoc 2:e004564. 2013
    ..Proton pump inhibitors (PPIs) may interfere with the metabolic activation of clopidogrel via inhibition of cytochrome P450 2C19, but the clinical implications remain unclear...
  3. doi request reprint Drug-drug interactions in cardiovascular catheterizations and interventions
    Steven P Dunn
    Department of Pharmacy Services, University of Virginia, Charlottesville, Virginia, USA
    JACC Cardiovasc Interv 5:1195-208. 2012
    ..This review will focus on drug-drug interactions that have the potential to affect procedural success, either through increases in immediate complications or compromising longer-term outcome...
  4. ncbi request reprint Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction
    Michael P Dorsch
    Department of Pharmacy Services, University of Michigan Hospitals and Health Centers, Ann Arbor, MI, USA
    Ann Pharmacother 41:737-41. 2007
    ..Estimates of biologic aspirin resistance vary from 5% to 60%, depending on the assay used. However, the relationship between biologic measurements of aspirin resistance and adverse clinical events remains unclear...